[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352159-105":59,"doc-detail-352159-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","challenges-in-identifying-paediatric-cancer-predisposition-syndromes-international-scope-survey-and-siope-expert-consensus-recommendations","Challenges in identifying paediatric cancer predisposition syndromes: international SCOPE survey and SIOPE expert consensus recommendations","","Cancer Predisposition Syndromes (CPS) are heritable genetic conditions that raise lifetime cancer risk, yet they are frequently underdiagnosed. An international SCOPE study assessed clinicians’ perspectives and barriers across Europe using a three-part survey of 185 paediatric haematology/oncology professionals from 22 countries, followed by a modified Delphi consensus with SIOP Europe experts. Over 40% reported low or uncertain confidence, especially in counselling families and interpreting germline findings. Reported barriers included limited screening guidelines and difficulties interpreting results; recommended improvements covered training, integrating screening into standard care, and developing patient-centred educational materials.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/challenges-in-identifying-paediatric-cancer-predisposition-syndromes-international-scope-survey-and-siope-expert-consensus-recommendations/352159/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/challenges-in-identifying-paediatric-cancer-predisposition-syndromes-international-scope-survey-and-siope-expert-consensus-recommendations/352159.png","ImageObject",300,407,{"name":92,"@type":93},"CatatanPagi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What are Cancer Predisposition Syndromes (CPS) and why are they important?","Question",{"text":113,"@type":114},"CPS are heritable genetic conditions that increase an individual’s lifetime risk of developing cancer. Timely recognition can affect treatment decisions and tumor surveillance, and it also relates to the elevated risk of second primary neoplasms in childhood cancer survivors.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was the SCOPE study conducted to evaluate clinician perspectives?",{"text":118,"@type":114},"The study used a three-part cross-sectional survey of paediatric haematology/oncology professionals, followed by a modified Delphi consensus process involving members of the SIOP Europe Host Genome Working Group.",{"name":120,"@type":111,"acceptedAnswer":121},"Which barriers were most commonly cited for CPS identification and care?",{"text":122,"@type":114},"The most cited barriers were lack of screening guidelines and difficulties interpreting results. Clinicians also reported low or uncertain confidence in tasks such as counselling families and interpreting germline genetic findings.",{"name":124,"@type":111,"acceptedAnswer":125},"What recommendations emerged from the Delphi consensus?",{"text":126,"@type":114},"Three recommendations were proposed: improve clinician training and communication strategies, integrate CPS screening into standard treatment plans, and develop accessible, patient-centred educational materials.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},352159,1790189099,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},962090894170,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","[www.nature.com/ejhg](www.nature.com/ejhg)  \nARTICLE OPEN   \nChallenges in identifying paediatric cancer predisposition syndromes: international SCOPE survey and SIOPE expert consensus recommendations  \nJakica Ćavar Pavić1,2, Noelle Cullinan 3, Marjolijn Jongmans4,5, Franck Bourdeaut 6, Karin Wadt7,8, Luca LoNigro9, Mark Davies10, Orli Michaeli 11, Sonja Strang-Karlsson12,13, Robin de Putter 14, Edith Sepulchre 15, Giovanni Cazzaniga 16, Rhoikos Furtwängler 1,17, Christiane Zweier 17,18, Jochen Rössler1 and Nicolas Waespe 1,17,19 ✉  \n© The Author(s) 2026  \n\n| | Cancer Predisposition Syndromes (CPS) are heritable genetic conditions associated with an increased risk of developing various cancers throughout life. While early identiﬁcation and tumour surveillance can improve outcomes, CPS are often underdiagnosed in clinical practice. To evaluate clinicians’ perspectives and identify barriers to CPS identiﬁcation and care across Europe, we conducted the SCOPE study: a three-part cross-sectional survey of paediatric haematology/oncology professionals, followed by a modiﬁed Delphi consensus process with members of the SIOP Europe Host Genome Working Group. A total of 185 paediatriconcologists from 22 countries participated in the survey. More than 40% of participants reported low or uncertain conﬁdence across different CPS-related tasks, particularly in counselling families (64.3%) and interpreting germline genetic ﬁndings (57.3%) . Access to clinical geneticists and dedicated CPS clinics were predictors of higher conﬁdence for some domains, while individual experience and institutional patient volume had limited inﬂuence. Regular use of universal CPS screening tools was low (42.3%), with most clinicians relying on personal judgement rather than structured criteria. The most cited barriers were lack of screening guidelines (57%) and difﬁculties in interpreting results (35.1%) . Regular training and workshops, availability of genetic counsellors or educators for patient support, and patient-friendly education material were most cited as areas of improvement. The Delphi process led to three recommendations: (1) improve clinician training and communication strategies, (2) integrate CPS screening into standard treatment plans, and (3) develop accessible, patient-centred educational materials. These recommendations highlight opportunities to enhance CPS care through structured support, interdisciplinary collaboration, and systematic screening | |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  | approaches. |  |\n|  |  |  |\n|  |  |  |\n|  | European Journal of Human Genetics (2026) 34:1374–1383; [https://doi.org/10.1038/s41431-026-02040-x](https://doi.org/10.1038/s41431-026-02040-x) |  |\n|  |  |  |\n\nBACKGROUND  \nCancer predisposition syndromes (CPS) are heritable genetic conditions that increase an individual’s lifetime risk of developing cancer. Recent studies report that 8–18% of childhood cancer patients have an underlying CPS [1–5]. Timely recognition of a CPS has various clinical implications which can include treatment modiﬁcations for the primary malignancy. For example, excess toxicity to certain chemotherapy agents and radiotherapy can occur in CPS such as Li-Fraumeni syndrome, Bloom Syndrome, or  \nNijmegen Breakage syndrome, while resistance to some chemotherapy agents such as temozolomide occurs in patients with mismatch repair deﬁciency, who may instead respond to newer agents such as immune checkpoint inhibitors [6–9] . Children with a CPS additionally have an elevated risk of developing second primary neoplasms (SPN) . Among childhood cancer survivors, SPN represent the second leading cause of mortality, after the primary malignancy [10–12] . A study conducted in Switzerland calculated the cumulative incidence of any SPN from diagnosis to 20 years  \n1Division of Paediatric Haematology and","cbCaiuZ2FggBiC7l","https://ap.wps.com/l/cbCaiuZ2FggBiC7l","pdf",714111,"English","# Background\n## Study design and objectives\n## Clinician confidence and key barriers\n## Recommendations from Delphi consensus","[{\"question\":\"What are Cancer Predisposition Syndromes (CPS) and why are they important?\",\"answer\":\"CPS are heritable genetic conditions that increase an individual’s lifetime risk of developing cancer. Timely recognition can affect treatment decisions and tumor surveillance, and it also relates to the elevated risk of second primary neoplasms in childhood cancer survivors.\"},{\"question\":\"How was the SCOPE study conducted to evaluate clinician perspectives?\",\"answer\":\"The study used a three-part cross-sectional survey of paediatric haematology/oncology professionals, followed by a modified Delphi consensus process involving members of the SIOP Europe Host Genome Working Group.\"},{\"question\":\"Which barriers were most commonly cited for CPS identification and care?\",\"answer\":\"The most cited barriers were lack of screening guidelines and difficulties interpreting results. Clinicians also reported low or uncertain confidence in tasks such as counselling families and interpreting germline genetic findings.\"},{\"question\":\"What recommendations emerged from the Delphi consensus?\",\"answer\":\"Three recommendations were proposed: improve clinician training and communication strategies, integrate CPS screening into standard treatment plans, and develop accessible, patient-centred educational materials.\"}]","Challenges in identifying paediatric cancer predisposition syndromes: international SCOPE survey and SIOPE expert consensus recommendations | PDF",1790098005,25,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e354c9820041fca90994cbea14bee01c.webp",983,1305,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5eec9887129f95c5faeb5722da3472f7.webp",982,1304,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4928bd16bf34bedf72c9914ef1393f39.webp",981,1303,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/31051b68d47d7821c7a12aad6ba09929.webp",980,1301]